Results 101 to 110 of about 42,544 (264)
Analysis of clinical and virologic features in Hepatitis B e Antigen (HbeAg)-negative and HbeAg-positive Egyptian chronic hepatitis B patients [PDF]
, 2020 Background: HBeAg\u2013negative chronic hepatitis B infection has a divergent clinical course from that of HBeAg-positive infection. Objectives: To analyze the frequency and to compare the different features of HBeAg-negative and HBeAg-positive chronic ...
Abdel Alem, Shereen +6 more
core
PLoS ONE, 2015 To describe the Hepatitis B e antigen(HBeAg) seroconversion related mutation profiles of the basal core promoter(BCP)/precore regions in e antigen seroconverted child patients, a cohort of 245 child patients with CHB and a control patients group of 92 ...
Yong Huang +7 more
doaj +1 more source
Factors predicting retreatment for HBeAg-negative patients. [PDF]
, 2019 Factors predicting retreatment for HBeAg-negative patients.
Tsung-Hui Hu (349887) +5 more
core +1 more source
Characterising Hepatitis D Virus in the UK From 2011 to 2021
Journal of Viral Hepatitis, Volume 33, Issue 9, September 2026.ABSTRACT Little is known about hepatitis B virus (HBV) and Hepatitis D virus (HDV) coinfection in the UK. HDV screening is recommended among all individuals with HBV, with coinfection associated with increased disease progression. Using data on HDV testing, shared by 11 laboratories in the UK who reported undertaking HDV testing, and national testing ...
R. Simmons +67 more
wiley +1 more source
JHEP ReportsBackground & Aims: The association between hepatitis B envelope antigen (HBeAg) seroclearance during long-term nucleos(t)ide analogue (NA) treatment and the risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB) remains ...
Hyunjae Shin +12 more
doaj +1 more source
Scholars Journal of Applied Medical SciencesIntroduction: Hepatitis B virus (HBV) infection remains a significant global health challenge, annually contributing to approximately one million deaths from complications such as liver failure, cirrhosis, and hepatocellular carcinoma (HCC). Methods: This observational, descriptive, cross-sectional study was conducted at the Armed Forces Institute of ...
Dr. (Major) Samia Mahmood +3 more
openaire +1 more source
Journal of Viral Hepatitis, Volume 33, Issue 9, September 2026.ABSTRACT To close gaps in implementing care of people with hepatitis B virus (HBV) infection in resource‐limited settings, we evaluated the accuracy of a novel liver point‐of‐care ultrasound (POCUS) protocol for hepatitis (PUSH) among front‐line non‐radiology healthcare workers in Zambia. At University Teaching Hospital in Lusaka, Zambia, from March to
Costanza Bertoni +15 more
wiley +1 more source
Therapeutic Advances in GastroenterologyBackground: As an uncommon serological pattern, the effect of hepatitis B e antigen/anti-hepatitis B e (HBeAg/anti-HBe) coexistence on peginterferon-α (Peg-IFN-α) therapy in patients with chronic hepatitis B (CHB) remains unknown.
Kaimin Song +9 more
doaj +1 more source
Indian Journal of Pathology and Microbiology, 2011 Background: Hepatitis B virus (HBV) is a potentially life-threatening liver infection which may progress to liver failure and cirrhosis. Intrahepatic expression patterns of viral antigens detected by immunohistochemistry may have prognostic implications ...
Aysegul Sari +5 more
doaj +1 more source
Journal of Viral Hepatitis, Volume 33, Issue 9, September 2026.ABSTRACT Chronic hepatitis B (CHB) and hepatitis D virus (HDV) coinfection are major causes of cirrhosis and hepatocellular carcinoma. The geographic distribution of CHB and alignment of anti‐HDV testing with CHB burden remain poorly defined. We aimed to examine if anti‐HDV testing and seropositivity align with areas of highest CHB burden.
Bryce Tkachuk +5 more
wiley +1 more source